Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy

ObjectiveTo explore the effect of targeted inhibition of angiotensin Ⅱ type 1 receptor (AGTR1) on renal fibrosis and podocyte damage in angiotensin Ⅱ-induced hypertensive nephropathy.MethodsThe murine experimental groups include normal control group,normal saline group,model group and drug group (&l...

Full description

Bibliographic Details
Published in:Linchuang shenzangbing zazhi
Main Authors: Zhang He-ping, Liu Jia-li, Tang Jin-cheng, Xie Rong, Yang Kun, Zhang Jie, Feng Jiang-chao
Format: Article
Language:Chinese
Published: Editorial Department of Journal of Clinical Nephrology 2022-04-01
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.04.009
_version_ 1849406261254160384
author Zhang He-ping
Liu Jia-li
Tang Jin-cheng
Xie Rong
Yang Kun
Zhang Jie
Feng Jiang-chao
author_facet Zhang He-ping
Liu Jia-li
Tang Jin-cheng
Xie Rong
Yang Kun
Zhang Jie
Feng Jiang-chao
author_sort Zhang He-ping
collection DOAJ
container_title Linchuang shenzangbing zazhi
description ObjectiveTo explore the effect of targeted inhibition of angiotensin Ⅱ type 1 receptor (AGTR1) on renal fibrosis and podocyte damage in angiotensin Ⅱ-induced hypertensive nephropathy.MethodsThe murine experimental groups include normal control group,normal saline group,model group and drug group (<italic>n</italic>=10 each).Normal control group was not treated,normal saline group underwent unilateral nephrectomy plus microosmotic pump infusion of normal saline,model group unilateral nephrectomy plus micro-osmotic pump perfusion with angiotensin Ⅱ,drug group unilateral nephrectomy plus an intraperitoneal injection of 50 mg/kg of Losartan 30 min before perfusion of angiotensin Ⅱ with a micro-osmotic pump.Blood pressures were measured for each group at pre-modeling and 2/4 weeks post-modeling.At 4 weeks post-modeling,enzyme-linked immunosorbent assay was employed for detecting 24 h urinary protein (24 h UP),serum creatinine (Scr) and urea nitrogen (BUN); hematoxylin-eosin (HE) staining for observing the pathological morphology of kidney tissue; Masson staining for detecting renal tissue fibrosis,observing the ultrastructural changes of podocytes with transmission electron microscope,immunofluorescent staining for detecting the expression of nephrin in podocytes of renal tissue,Western blot for detecting the expressions of α-smooth muscle actin (α-SMA),type Ⅰ/Ⅲ collagen (collagen-Ⅰ/Ⅲ),nephrin,podocin and synaptopodin.ResultsCompared with normal control group,blood pressure rose after modeling [modeling for 2 weeks:(148.92±12.56) mmHg <italic>vs </italic>(109.18±9.43) mmHg; modeling for 4 weeks:(150.92±13.74) mmHg <italic>vs</italic> (117.68±10.73) mmHg,1 mmHg = 0.133 kPa] and 24 h UP [(2.02±0.18) mg/24h <italic>vs</italic> (3.88±0.34) mg/24h <italic>vs</italic> (0.37±0.02) mg/24h],Scr [(11.34±0.97) μmol/L <italic>vs</italic>(13.92±1.16) μmol/L <italic>vs</italic> (9.18±0.87) μmol/L] and BUN [(11.34±1.09) mmol/L <italic>vs</italic> (14.55±1.30) mmol/L <italic>vs</italic> (7.71±0.73) mmol/L] spiked in normal saline and model groups,renal tubules appeared atrophic and necrotic with vacuolar degeneration,and epithelial cells sloughed off,heavy infiltrate of inflammatory cells,accompanied by obvious fibrosis,podocyte foot process thickened and merged,slit membrane disappeared,fluorescent intensity of nephrin declined,protein expression levels of α-SMA and collagen-Ⅰ/Ⅲ spiked while protein expression levels of nephrin,podocin and synaptopodin declined (<italic>P</italic>&lt;0.01).Compared with model group,blood pressure of drug group dropped [2 weeks of modeling:(125.08±10.79) mmHg <italic>vs </italic>(148.92±12.56) mmHg; 4 weeks of modeling:(122.78±10.07) mmHg <italic>vs</italic>(150.92±13.74) mmHg],24 h UP [(1.25±0.11) mg/24h <italic>vs </italic>(3.88±0.34) mg/24h],Scr [(10.33±0.84) μmol/L <italic>vs </italic>(13.92±1.16) μmol/L] and BUN [(8.96±0.81) mmol/L <italic>vs </italic>(14.55±1.30) mmol/L] decreased,renal tubular atrophy,necrosis and vacuolar degeneration were alleviated,minimal infiltration of inflammatory cell,degree of fibrosis lessened,foot process thickened and fusion phenomenon improved.At the same time,fluorescent intensity of nephrin increased,rotein expression levels of α-SMA and collagen-Ⅰ/Ⅲ dropped while protein expression levels of nephrin,podocin and synaptopodin spiked (<italic>P</italic>&lt;0.01).ConclusionInhibition of AGTR1 may reduce renal fibrosis in a murine model of hypertensive nephropathy induced by angiotensinⅡand at the same time reduce podocyte damage.
format Article
id doaj-art-a856e3c4fd4e4e939459522652ce4bf3
institution Directory of Open Access Journals
issn 1671-2390
language zho
publishDate 2022-04-01
publisher Editorial Department of Journal of Clinical Nephrology
record_format Article
spelling doaj-art-a856e3c4fd4e4e939459522652ce4bf32025-08-20T03:53:07ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902022-04-012231532225398554Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive NephropathyZhang He-pingLiu Jia-liTang Jin-chengXie RongYang KunZhang JieFeng Jiang-chaoObjectiveTo explore the effect of targeted inhibition of angiotensin Ⅱ type 1 receptor (AGTR1) on renal fibrosis and podocyte damage in angiotensin Ⅱ-induced hypertensive nephropathy.MethodsThe murine experimental groups include normal control group,normal saline group,model group and drug group (<italic>n</italic>=10 each).Normal control group was not treated,normal saline group underwent unilateral nephrectomy plus microosmotic pump infusion of normal saline,model group unilateral nephrectomy plus micro-osmotic pump perfusion with angiotensin Ⅱ,drug group unilateral nephrectomy plus an intraperitoneal injection of 50 mg/kg of Losartan 30 min before perfusion of angiotensin Ⅱ with a micro-osmotic pump.Blood pressures were measured for each group at pre-modeling and 2/4 weeks post-modeling.At 4 weeks post-modeling,enzyme-linked immunosorbent assay was employed for detecting 24 h urinary protein (24 h UP),serum creatinine (Scr) and urea nitrogen (BUN); hematoxylin-eosin (HE) staining for observing the pathological morphology of kidney tissue; Masson staining for detecting renal tissue fibrosis,observing the ultrastructural changes of podocytes with transmission electron microscope,immunofluorescent staining for detecting the expression of nephrin in podocytes of renal tissue,Western blot for detecting the expressions of α-smooth muscle actin (α-SMA),type Ⅰ/Ⅲ collagen (collagen-Ⅰ/Ⅲ),nephrin,podocin and synaptopodin.ResultsCompared with normal control group,blood pressure rose after modeling [modeling for 2 weeks:(148.92±12.56) mmHg <italic>vs </italic>(109.18±9.43) mmHg; modeling for 4 weeks:(150.92±13.74) mmHg <italic>vs</italic> (117.68±10.73) mmHg,1 mmHg = 0.133 kPa] and 24 h UP [(2.02±0.18) mg/24h <italic>vs</italic> (3.88±0.34) mg/24h <italic>vs</italic> (0.37±0.02) mg/24h],Scr [(11.34±0.97) μmol/L <italic>vs</italic>(13.92±1.16) μmol/L <italic>vs</italic> (9.18±0.87) μmol/L] and BUN [(11.34±1.09) mmol/L <italic>vs</italic> (14.55±1.30) mmol/L <italic>vs</italic> (7.71±0.73) mmol/L] spiked in normal saline and model groups,renal tubules appeared atrophic and necrotic with vacuolar degeneration,and epithelial cells sloughed off,heavy infiltrate of inflammatory cells,accompanied by obvious fibrosis,podocyte foot process thickened and merged,slit membrane disappeared,fluorescent intensity of nephrin declined,protein expression levels of α-SMA and collagen-Ⅰ/Ⅲ spiked while protein expression levels of nephrin,podocin and synaptopodin declined (<italic>P</italic>&lt;0.01).Compared with model group,blood pressure of drug group dropped [2 weeks of modeling:(125.08±10.79) mmHg <italic>vs </italic>(148.92±12.56) mmHg; 4 weeks of modeling:(122.78±10.07) mmHg <italic>vs</italic>(150.92±13.74) mmHg],24 h UP [(1.25±0.11) mg/24h <italic>vs </italic>(3.88±0.34) mg/24h],Scr [(10.33±0.84) μmol/L <italic>vs </italic>(13.92±1.16) μmol/L] and BUN [(8.96±0.81) mmol/L <italic>vs </italic>(14.55±1.30) mmol/L] decreased,renal tubular atrophy,necrosis and vacuolar degeneration were alleviated,minimal infiltration of inflammatory cell,degree of fibrosis lessened,foot process thickened and fusion phenomenon improved.At the same time,fluorescent intensity of nephrin increased,rotein expression levels of α-SMA and collagen-Ⅰ/Ⅲ dropped while protein expression levels of nephrin,podocin and synaptopodin spiked (<italic>P</italic>&lt;0.01).ConclusionInhibition of AGTR1 may reduce renal fibrosis in a murine model of hypertensive nephropathy induced by angiotensinⅡand at the same time reduce podocyte damage.http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.04.009Hypertensive nephropathyAngiotensin Ⅱ type 1 receptorFibrosisPodocyte damage
spellingShingle Zhang He-ping
Liu Jia-li
Tang Jin-cheng
Xie Rong
Yang Kun
Zhang Jie
Feng Jiang-chao
Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
Hypertensive nephropathy
Angiotensin Ⅱ type 1 receptor
Fibrosis
Podocyte damage
title Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
title_full Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
title_fullStr Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
title_full_unstemmed Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
title_short Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
title_sort inhibition of angiotensin ii type 1 receptor on renal fibrosis and podocyte damage in angiotensin ii induced hypertensive nephropathy
topic Hypertensive nephropathy
Angiotensin Ⅱ type 1 receptor
Fibrosis
Podocyte damage
url http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.04.009
work_keys_str_mv AT zhangheping inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT liujiali inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT tangjincheng inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT xierong inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT yangkun inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT zhangjie inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy
AT fengjiangchao inhibitionofangiotensiniitype1receptoronrenalfibrosisandpodocytedamageinangiotensiniiinducedhypertensivenephropathy